Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Current Opinion in Supportive and Palliative Care
|
August 9, 2012
Multiple myeloma: improved outcomes with new therapeutic approaches
Shahrooz Eshaghian, James R Berenson
International Journal of Hematology
|
November 1, 2011
Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH)
Ling Cao, William Dean Wallace, Shahrooz Eshaghian, et al.
Open Medicine (Warsaw, Poland)
|
July 22, 2017
Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia
Hyang-Min Byun, Shahrooz Eshaghian, Dan Douer, et al.
Journal of Medical Virology
|
March 21, 2012
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County
Theodoros Kelesidis, Romney Humphries, Dawn Terashita, et al.
Targeted Oncology
|
September 8, 2023
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
Scott Jew, Sean Bujarski, Bernard Regidor, et al.
Clinical Infection in Practice
|
December 15, 2021
Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination
Samuel D Stampfer, Marissa-Skye Goldwater, Sean Bujarski, et al.
Leukemia & Lymphoma
|
November 25, 2021
A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma
David Yashar, Tanya M Spektor, Daisy Martinez, et al.
Cancer Reports (Hoboken, N.J.)
|
March 9, 2023
Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma
Samuel D Stampfer, Sean Bujarski, Marissa-Skye Goldwater, et al.
Annals of Hematology
|
December 10, 2016
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
Ariana Berenson, Suzie Vardanyan, Michael David, et al.
Annals of Hematology
|
December 4, 2016
Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic
Ariana Berenson, Suzie Vardanyan, Michael David, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Current Opinion in Supportive and Palliative Care
|
August 9, 2012
Multiple myeloma: improved outcomes with new therapeutic approaches
Shahrooz Eshaghian, James R Berenson
International Journal of Hematology
|
November 1, 2011
Glomerular hemophagocytic macrophages in a patient with proteinuria and clinical and laboratory features of hemophagocytic lymphohistiocytosis (HLH)
Ling Cao, William Dean Wallace, Shahrooz Eshaghian, et al.
Open Medicine (Warsaw, Poland)
|
July 22, 2017
Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia
Hyang-Min Byun, Shahrooz Eshaghian, Dan Douer, et al.
Journal of Medical Virology
|
March 21, 2012
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County
Theodoros Kelesidis, Romney Humphries, Dawn Terashita, et al.
Targeted Oncology
|
September 8, 2023
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients
Scott Jew, Sean Bujarski, Bernard Regidor, et al.
Clinical Infection in Practice
|
December 15, 2021
Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination
Samuel D Stampfer, Marissa-Skye Goldwater, Sean Bujarski, et al.
Leukemia & Lymphoma
|
November 25, 2021
A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma
David Yashar, Tanya M Spektor, Daisy Martinez, et al.
Cancer Reports (Hoboken, N.J.)
|
March 9, 2023
Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma
Samuel D Stampfer, Sean Bujarski, Marissa-Skye Goldwater, et al.
Annals of Hematology
|
December 10, 2016
Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib
Ariana Berenson, Suzie Vardanyan, Michael David, et al.
Annals of Hematology
|
December 4, 2016
Improved clinical outcomes for multiple myeloma patients treated at a single specialty clinic
Ariana Berenson, Suzie Vardanyan, Michael David, et al.
Page
of 2